Cargando…
Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease associated with systemic changes in immune response, which might be associated with coronavirus disease 2019 (COVID-19) severity. The aim of this study was to investigate the impact of NAFLD on COVID-19 severity an...
Autores principales: | Vrsaljko, Nina, Samadan, Lara, Viskovic, Klaudija, Mehmedović, Armin, Budimir, Jelena, Vince, Adriana, Papic, Neven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903409/ https://www.ncbi.nlm.nih.gov/pubmed/35287335 http://dx.doi.org/10.1093/ofid/ofac073 |
Ejemplares similares
-
311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19
por: Vrsaljko, Nina, et al.
Publicado: (2021) -
COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
por: Močibob, Loris, et al.
Publicado: (2022) -
Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection
por: Šamadan, Lara, et al.
Publicado: (2021) -
Distinct Cytokine Profiles in Severe COVID-19 and Non-Alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2022) -
TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study
por: Susak, Frano, et al.
Publicado: (2023)